Bluejay DiagnosticsBJDX
13F holders, Q4 2024 (December 31)3holders
$4.87avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Bluejay Diagnostics Inc. (BJDX) in their 13F filings. The largest holders were UBS Group AG ($9K), Tower Research Capital LLC (TRC) ($3K) and Bank of America Corp. ($19).
- Company
- Bluejay Diagnostics Inc.
- CUSIP
- 095633509
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $12K |
| Exits | 0 | $0 |
Ownership 3 holders
| UBS Group AG | 0.00% | New | 1,945 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 554 | $3K |
| Bank of America Corp. | 0.00% | New | 4 | $19 |
"% of holder's portfolio" is BJDX's weight in each manager's 13F, not the share of Bluejay Diagnostics Inc. the manager owns.